Genmab A (GMAB) Total Liabilities (2023 - 2025)

Genmab A's Total Liabilities history spans 3 years, with the latest figure at $7.0 billion for Q4 2025.

  • For Q4 2025, Total Liabilities rose 450.2% year-over-year to $7.0 billion; the TTM value through Dec 2025 reached $7.0 billion, up 450.2%, while the annual FY2025 figure was $7.0 billion, 450.2% up from the prior year.
  • Total Liabilities reached $7.0 billion in Q4 2025 per GMAB's latest filing, up from $1.3 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $7.0 billion in Q4 2025 to a low of $545.0 million in Q4 2023.
  • Average Total Liabilities over 3 years is $2.9 billion, with a median of $1.3 billion recorded in 2024.
  • Peak YoY movement for Total Liabilities: skyrocketed 134.31% in 2024, then surged 450.2% in 2025.
  • A 3-year view of Total Liabilities shows it stood at $545.0 million in 2023, then soared by 134.31% to $1.3 billion in 2024, then soared by 450.2% to $7.0 billion in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Total Liabilities are $7.0 billion (Q4 2025), $1.3 billion (Q4 2024), and $545.0 million (Q4 2023).